IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTANEO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.075
AS - Asia 3.107
EU - Europa 2.737
SA - Sud America 581
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 11.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.983
CN - Cina 1.268
SG - Singapore 990
UA - Ucraina 774
DE - Germania 530
BR - Brasile 476
IT - Italia 438
HK - Hong Kong 321
FR - Francia 233
FI - Finlandia 186
VN - Vietnam 178
GB - Regno Unito 159
RU - Federazione Russa 151
TR - Turchia 119
IE - Irlanda 110
IN - India 71
CA - Canada 47
AR - Argentina 41
BD - Bangladesh 38
ZA - Sudafrica 32
SE - Svezia 28
MX - Messico 26
PL - Polonia 24
EC - Ecuador 22
IQ - Iraq 21
NL - Olanda 18
BE - Belgio 17
JP - Giappone 17
ES - Italia 16
PK - Pakistan 13
CO - Colombia 12
ID - Indonesia 12
LT - Lituania 11
AT - Austria 10
EU - Europa 10
PY - Paraguay 8
UZ - Uzbekistan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 6
DZ - Algeria 6
NG - Nigeria 6
AZ - Azerbaigian 5
IL - Israele 5
MA - Marocco 5
PA - Panama 5
SA - Arabia Saudita 5
UY - Uruguay 5
AL - Albania 4
JM - Giamaica 4
KE - Kenya 4
PH - Filippine 4
RS - Serbia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
EG - Egitto 3
IR - Iran 3
LB - Libano 3
MK - Macedonia 3
MU - Mauritius 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
Totale 11.581
Salva come PNG Salva come JPEG
Città #
Jacksonville 535
Singapore 492
Fairfield 447
Woodbridge 422
Ashburn 359
Hong Kong 321
Houston 304
Beijing 274
Ann Arbor 239
The Dalles 220
Princeton 212
Cambridge 209
San Jose 206
Nanjing 198
Wilmington 198
Seattle 173
Chandler 143
Dublin 110
New York 108
Los Angeles 98
Istanbul 97
Lauterbourg 92
Helsinki 79
Nanchang 70
Milan 67
Ho Chi Minh City 63
Moscow 59
Des Moines 57
Hebei 57
Buffalo 51
Changsha 45
Shenyang 45
Hanoi 42
São Paulo 40
San Diego 35
Kunming 34
Dallas 33
Shanghai 33
Tianjin 32
Jiaxing 31
Lancaster 31
Jinan 28
Munich 28
San Francisco 27
Redondo Beach 21
Orem 20
Rome 20
Toronto 19
Brooklyn 17
Brussels 17
Chicago 17
Hangzhou 16
Johannesburg 16
London 16
Rio de Janeiro 16
Santa Clara 16
Atlanta 15
Charlotte 15
Nürnberg 15
Tokyo 15
Verona 15
Warsaw 15
Zhengzhou 15
Brescia 13
Mexico City 13
Haikou 12
San Mateo 12
Chennai 11
Lanzhou 11
Augusta 10
Belo Horizonte 10
Dhaka 10
Guayaquil 10
Kocaeli 10
Monmouth Junction 10
Ningbo 10
Phoenix 10
Curitiba 9
Dearborn 9
Frankfurt am Main 9
Guangzhou 9
Taiyuan 9
Trieste 9
Da Nang 8
Denver 8
Taizhou 8
Turku 8
Vienna 8
Amsterdam 7
Baghdad 7
Boston 7
Brasília 7
Fuzhou 7
Genoa 7
Haiphong 7
Itajaí 7
Lucera 7
Manchester 7
Miami 7
Montreal 7
Totale 7.090
Salva come PNG Salva come JPEG
Nome #
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 204
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 194
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 183
Desensibilizzazione orale alla rifampicina: descrizione di un nuovo protocollo. 159
CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. 158
In vitro cell death of activated lymphocytes in Omenn's syndrome 153
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 151
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 150
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 148
Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection 148
Studio con TC ad alta risoluzione (HRCT) dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 145
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 145
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 136
Circulating immune complexes in human acute leukaemia. 136
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 135
Esposizione a latice nelle aziende sanitarie: esperienze pratiche 134
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 131
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 130
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. 130
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 129
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 127
Prevenzione delle reazioni allergiche in pazienti sensibilizzati a latice 125
Anti beta2-glycoprotein I antibodies: clinical significance. 125
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 124
Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. 124
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 123
Antiperinuclear factor in psoriatic arthropathy 121
Antinuclear antibodies in psoriatic arthritis and its subgroups 120
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 120
Nonorgan specific autoantibodies and heart damage. 119
Oesophageal manometry in early and definite systemic sclerosis. 118
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 116
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 115
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis 114
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 114
Antiphospholipid antibodies and malignancies 114
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 114
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell-death 113
Vasculite orticarioide: valutazione clinica, laboratoristica e terapeutica di 17 pazienti. 113
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 113
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicentre prospective study. 113
Anticorpi antinucleo e artrite psoriasica 113
Pregnancy in systemic sclerosis: a prospective study 113
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 113
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 113
The anti-beta-2 glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. 111
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. 111
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 111
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 111
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers 111
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 110
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 110
Role of anti-prothrombin in antiphospholipid syndrome. 110
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 110
Chilblain Lupus Erythematosus (CL) è associato ad anticorpi anti SSA/Ro 108
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 107
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 106
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 105
Systemic lupus erythematosus and pregnancy: a prospective study. 105
Antinuclear antibodies and psoriatic arthritis 104
NEUROLOGICAL MANIFESTATIONS IN 169 PATIENTS WITH PAPS: WHICH SIGNIFICANCE FOR SMALL HYPERINTENSE WHITE MATTER LESIONS AT MAGNETIC RESONANCE IMAGING? 104
Proliferazioni di cloni di tipo Th2 con fenotipo CD3- CD4+. Studio di 2 casi. 103
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 103
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of Low-dose versus high-dose intravenous cyclophosphamide. 102
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. 102
Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. 101
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. 100
ANTICORPI ANTIFOSFOLIPIDI E NEOPLASIE (aPL E NEOPLASIE) 99
Esophageal Dysfunction in Patients with Definite and Early Systemic Sclerosis 98
Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. 96
Lymphadenopathic and oropharyngeal Kaposi's sarcoma in a drug addict with acquired immunodeficiency syndrome. Immunological abnormalities in peripheral blood and lymphoid tissue 96
PREGNANCY OUTCOMES IN WOMEN EXPOSED TO BIOLOGIC TREATMENT AND AFFECTED BY CHRONIC ARTHRITIS 95
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 93
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 93
Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients 93
IL METHOTREXATE (MTX) E I GENOTIPI DELLA METILENTETRAIDROFOLATOREDUTTASI (MTHFR) NEL TRATTAMENTO DI PAZIENTI ITALIANI CON MALATTIE REUMATICHE 92
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 92
Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. 92
The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies. 92
Chillblain lupus erythematosus is associated with antibodies to SSA/Ro 91
[A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases] Studio con tomografia computerizzata con alta risoluzione dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 90
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). 89
Antiperinuclear factor (APF) in patients with psoriasic arthtritis 87
L'orticaria. 85
Chilblain Lupus Erythematosus (CL) is associated with antibodies SSA/Ro 84
Esofagopatia sclerodermia in pazienti con sclerosi sistemica (SSC) “precoce” secondo Le Roy-Mesdger: confronto con altri subset di malattia. Studio clinico-manometrico di 181 pazienti 84
Lessons from the "Euro-Lupus Cohort". 84
Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 84
Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients 83
Oesophageal dysfunction in patients with definite and early systemic sclerosis 83
TERAPIE BIOLOGICHE E GRAVIDANZA: RISULTATI DI UNO STUDIO MULTICENTRICO ITALIANO 83
Discordance for Systemic LupusErythematosus and Hyper IgE Syndrome in a pair of monozygous twins 82
Chronic urticaria induced by eradication therapy of Helicobacter pilori: a case report. 82
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 81
Pretransplant antitumor conditioning (fTBI dose) correlates with bone marrow histology at day 0 in leukemic patients. 80
European Working Party on Systemic Lupus Erythematosus. Lessons from the "Euro-Lupus Cohort". 78
European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". 77
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases 75
Antiphospholipid antibodies and intestinal pathology 75
Lupus neonatale: manifestazioni cliniche e rischio di blocco cardiaco congenito in neonati da madri con anticorpi anti-Ro/SSA. 72
Totale 11.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021263 0 0 0 0 0 0 0 0 0 78 166 19
2021/2022763 29 152 14 56 12 27 22 56 39 87 70 199
2022/2023576 113 5 5 20 58 173 3 54 96 3 16 30
2023/2024630 53 19 41 31 13 102 21 23 216 3 1 107
2024/20251.500 2 7 5 177 218 116 99 52 149 127 362 186
2025/20263.011 345 503 245 515 305 192 421 125 162 198 0 0
Totale 11.650